InspireMD, Inc. Series B Warrants
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NSPRZ and buy or sell other stocks, ETFs, and their options commission-free!About NSPRZ
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions.
CEOMarvin L. Slosman, MBA
CEOMarvin L. Slosman, MBA
Employees—
Employees—
HeadquartersMiami, Florida
HeadquartersMiami, Florida
Founded2005
Founded2005
Employees—
Employees—
NSPRZ Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high—
52 Week high—
52 Week low—
52 Week low—
NSPRZ News
TipRanks 24h
Insiders Make Bold Moves as InspireMD Directors Load Up on SharesNew insider activity at InspireMD ( (NSPR) ) has taken place on May 8, 2026. Unlock hedge fund-level data and powerful investing tools for smarter, sharper dec...
TipRanks 5d
InspireMD reports Q1 EPS (16c), consensus (18c)Reports Q1 revenue $3.4M, consensus $2.7M. “Our first quarter results reflect strong underlying demand and consistent clinical outcomes for our CGuard carotid s...